Related Experiment Videos
A proteomic study of SUMO-2 target proteins
Alfred C O Vertegaal1, Stephen C Ogg, Ellis Jaffray
1Wellcome Trust Biocentre, University of Dundee, Dundee DD1 5EH, United Kingdom.
The Journal of Biological Chemistry
|June 4, 2004
Summary
Researchers identified novel targets for SUMO-2, a key protein modification. This study advances understanding of SUMO-2
Area of Science:
- Molecular Biology
- Biochemistry
- Cell Biology
Background:
- The SUMO (Small Ubiquitin-like Modifier) protein family, including SUMO-1, SUMO-2, and SUMO-3, plays a crucial role in post-translational modifications in vertebrates.
- While numerous SUMO-1 targets have been identified, the functional targets of SUMO-2 remain largely uncharacterized.
- Understanding SUMO-2 targets is essential for elucidating its specific biological roles.
Purpose of the Study:
- To identify novel endogenous target proteins of SUMO-2.
- To characterize the function and localization of SUMO-2 conjugates.
- To validate the identified targets using biochemical and mass spectrometry approaches.
Main Methods:
- Establishment of a stable HeLa cell line expressing His6-tagged SUMO-2.
- Affinity purification of His6-tagged SUMO-2 conjugates from nuclear fractions.
- Identification of purified proteins using mass spectrometry.
- Validation of identified targets through biochemical assays.
Main Results:
- Eight novel potential SUMO-2 target proteins were identified.
- Three identified proteins—SART1, heterogeneous nuclear ribonucleoprotein (RNP) M, and U5 small nuclear RNP 200-kDa helicase—are involved in RNA metabolism.
- SART1 and heterogeneous nuclear RNP M were confirmed as genuine SUMO-2 targets.
Conclusions:
- The study successfully identified novel SUMO-2 target proteins, expanding the known interactome of SUMO-2.
- The findings highlight the involvement of SUMO-2 in RNA metabolism through its regulation of specific proteins.
- The established methodology provides a robust platform for future SUMO-2 target identification and functional studies.